• For over 10 years, we have advised a major pharmaceutical multinational on their day-to-day operations, including the negotiation of numerous distribution contracts, patient support program agreements, and contracts for the provision of medicines and medical devices with public and private entities.
  
  
• We have obtained licenses for cannabis cultivation for one of our clients, which has enhanced their product development, hemp exportation, and, in particular, the legal cultivation and commercialization of hemp.
  
  
• In the regulatory context, we have provided highly effective assistance in obtaining sanitary registrations and mandatory health notifications for hundreds of products, particularly pharmaceuticals, for clients from various countries, boosting the local market and facilitating foreign investment.
  
  
• Through a complex and detailed strategy, we have achieved the reclassification of dozens of products to ensure their availability in the OCT and OTX markets.
  
  
• We have provided comprehensive and complete advice to pharmaceutical companies on drug pricing processes, particularly for new and strategic medications.
  
  
• We have represented several pharmaceutical companies in challenging price ceilings, achieving new prices that appropriately reflect the characteristics of the products.
  
  
• We have advised various companies on biotechnology issues and measures for implementing relevant regulations.
  
  
• We have handled numerous litigations before the relevant authorities in administrative and civil branches, achieving favorable results and preventing sanctions for our clients and the analysis of their products.
  
  
• We have represented a pharmaceutical laboratory before administrative and judicial authorities to suspend several health registrations that were erroneously granted.
  
  
• We advised a pharmaceutical laboratory to challenge the price ceilings imposed by the regulator on certain medications under the price-setting regime.
• We advised leading pharmacy chains in Ecuador on State regulation of the sector.
  
  
• We provide ongoing support to our clients regarding the use of personal data of their customers and stakeholders.
  
  
• We have advised negotiating alternative contracting models with the State, including leases, loan agreements, and donations of medications, equipment, and medical devices.
  
  
• We advise and support several pharmaceutical and medical device laboratories in various stages of public procurement processes.
  
  
• We have advised several pharmaceutical laboratories on implementing programs for controlling and ensuring compliance with regulations regarding the advertising of medications and medical devices.
  
  
• We advised a pharmaceutical laboratory in creating a scheme for medical representatives and advertising prescription medications.
  
  
• During the COVID-19 pandemic, we implemented dozens of biosafety programs across various industries.
  
  
• We provided advisory services to pharmaceutical companies in negotiating representation, agency, commission, distribution, and logistics operation contracts.
  
  
• We successfully advised one of the leading distribution groups in an investigation by the Ecuadorian competition authority for alleged market power abuse.
  
  
• We advised a pharmaceutical laboratory on their entire scheme for agency, distribution, and pricing of their products in Ecuador.
  
  
• We have advised a pharmaceutical laboratory on their product discount scheme, ensuring compliance with competition regulations and avoiding discriminatory or predatory practices.
  
  
• We advised a pharmaceutical company in an investigation initiated by the competition authority concerning alleged refusal to supply products to public hospitals.
  
  
• We provided advisory services to pharmaceutical laboratories and distributors in investigations regarding potential collusive agreements, price discrimination, and abuse of power before the competition authority.
  
  
• We advised leading pharmacy chains in Ecuador during investigations into complaints of price discrimination and exclusive distribution.
  
  
• We successfully advised several pharmaceutical companies in an investigation for alleged unfair practices in drug labeling.
  
  
• We have implemented more than a dozen preventive audits and competition compliance programs in the pharmaceutical, food, and logistics industries, among others.
  
  

These cases highlight the importance of specialized and up-to-date legal advice in a sector where the intersection of scientific innovation, intellectual property rights, and regulatory norms is crucial for the success and protection of the parties involved.